TickerFacts.

BioXcel Therapeutics, Inc. (BTAIQ): Operating Income

Annual figures by period end, from SEC filings.

-$50.46M
Year ended 2025-12-31
-$44.93M
Trailing 12 months to 2026-06-30
2017-12-31: -$4.54M2018-12-31: -$19.96M2019-12-31: -$33.60M2020-12-31: -$82.30M2021-12-31: -$106.94M2022-12-31: -$159.65M2023-12-31: -$171.78M2024-12-31: -$67.25M2025-12-31: -$50.46M-$50.46M
2017-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$50.46Mn/m2026-03-27, From 2025-01-01
2024-12-31-$67.25Mn/m2026-03-27, From 2024-01-01
2023-12-31-$171.78Mn/m2025-03-28, From 2023-01-01
2022-12-31-$159.65Mn/m2024-03-22, From 2022-01-01
2021-12-31-$106.94Mn/m2023-03-16, From 2021-01-01
2020-12-31-$82.30Mn/m2022-03-11, From 2020-01-01
2019-12-31-$33.60Mn/m2021-03-12, From 2019-01-01
2018-12-31-$19.96Mn/m2020-03-09, From 2018-01-01
2017-12-31-$4.54Mn/a2019-03-12, From 2017-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
BioXcel Therapeutics, Inc. (BTAIQ)2025-12-31-$50.46Mn/m
Polomar Health Services, Inc. (PMHS)2025-12-31-$10.55Mn/m
Vaccinex, Inc. (VCNX)2024-12-31-$18.73Mn/m
Lexaria Bioscience Corp. (LEXX)2025-08-31-$11.88Mn/m
Yarrow Bioscience, Inc. (YARW)2025-12-31-$29.75Mn/m
Silence Therapeutics plc (SLN)2025-12-31-$91.08Mn/m
Quantum Cyber N.V. (QUCY)2025-12-31-$16.14Mn/m
Lipella Pharmaceuticals Inc. (LIPO)2024-12-31-$5.08Mn/m
Hyperion Defi, Inc. (HYPD)2025-12-31-$46.72Mn/m

Compare BTAIQ, PMHS, VCNX, LEXX side by side · Screen every company in Pharmaceutical Preparations ↗